Delving into the Latest Updates on ACTH4-10Pro8-Gly9-Pro10 with Synapse

Overview

Basic Info

Drug Type

Synthetic peptide

Synonyms-

Target-

Mechanism-

Therapeutic Areas

Nervous System Diseases

Active Indication-

Inactive Indication

Neurotoxicity Syndromes

Originator Organization

Universitas Sumatera Utara

Active Organization-

Inactive Organization

Universitas Sumatera Utara

Drug Highest PhasePendingClinical

First Approval Date-

Regulation-

The compound ACTH4-10Pro8-Gly9-Pro10 is a synthetic analog molecule of an adrenocorticotropic hormone (ACTH) short fragment. That is free from hormonal effects and has neuromodulatory effects. We investigate the neuroprotective effects of ACTH4-10Pro8-Gly9-Pro10 can lessen neurotoxicity against ketamine in neonatal rats by looking at BDNF expression in the cortex and hippocampus tissue as well as BDNF blood levels.

Start Date01 Aug 2021

Sponsor / Collaborator

Universitas Sumatera Utara

100 Clinical Results associated with ACTH4-10Pro8-Gly9-Pro10

Login to view more data

100 Translational Medicine associated with ACTH4-10Pro8-Gly9-Pro10

Login to view more data

100 Patents (Medical) associated with ACTH4-10Pro8-Gly9-Pro10

Login to view more data

100 Deals associated with ACTH4-10Pro8-Gly9-Pro10

Login to view more data